Pathophysiology and treatment of septic shock in neonates

Clinics in Perinatology

Volumn 37, Issue 2, 2010, Pages 439-479

  Wynn, James L ^a   Wong, Hector R ^b  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Neonate; Pathophysiology; Sepsis; Shock; Treatment

Indexed keywords

ACUTE PHASE PROTEIN; ADRENALIN; ANTIBIOTIC AGENT; ARGIPRESSIN; CATECHOLAMINE; CELL ADHESION MOLECULE; CELL PROTEIN; CHEMOKINE; CYTOKINE; DAMAGE ASSOCIATED MOLECULAR PATTERN; DOBUTAMINE; DOPAMINE; GLUCOCORTICOID; HYDROCORTISONE; INOTROPIC AGENT; MILRINONE; NORADRENALIN; OPSONIN; PATTERN ASSOCIATED MOLECULAR PATTERN; PATTERN RECOGNITION RECEPTOR; TERLIPRESSIN; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; COMPLEMENT; SIGNAL PEPTIDE;

BLOOD CLOTTING DISORDER; CARDIOVASCULAR DISEASE; COMPLEMENT ACTIVATION; CYTOKINE PRODUCTION; DISEASE SEVERITY; DRUG DOSE ESCALATION; DRUG MEGADOSE; ENDOTHELIAL DYSFUNCTION; EXTRACORPOREAL OXYGENATION; EXTREMELY LOW BIRTH WEIGHT; FLUID RESUSCITATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOMICS; HEMODYNAMICS; HIGH RISK INFANT; HOST RESISTANCE; HUMAN; HYPOTENSION; IMMUNE RESPONSE; INFECTION RISK; INNATE IMMUNITY; LEUKOCYTE FUNCTION; LOW DRUG DOSE; MICROBIOLOGICAL EXAMINATION; MORBIDITY; MORTALITY; MULTIPLE ORGAN FAILURE; NEUTROPHIL; NEWBORN; NEWBORN SEPSIS; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PATIENT MONITORING; PRACTICE GUIDELINE; PREMATURITY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEOMICS; RESUSCITATION; REVIEW; RISK FACTOR; SEPTIC SHOCK; SIGNAL TRANSDUCTION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; IMMUNOLOGY; MICROBIOLOGY; PASSIVE IMMUNIZATION; PROCEDURES; SHOCK, SEPTIC; VASCULAR ENDOTHELIUM;

ACUTE-PHASE PROTEINS; ANTI-INFECTIVE AGENTS; BLOOD COAGULATION DISORDERS; COMPLEMENT SYSTEM PROTEINS; ENDOTHELIUM, VASCULAR; GENOMICS; HUMANS; HYDROCORTISONE; IMMUNITY, INNATE; IMMUNITY, MATERNALLY-ACQUIRED; INFANT, NEWBORN; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MULTIPLE ORGAN FAILURE; NEUTROPHILS; OPSONIN PROTEINS; PROTEOMICS; RESUSCITATION; RISK FACTORS; SHOCK, SEPTIC; SIGNAL TRANSDUCTION;

EID: 77953516842     PISSN: 00955108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clp.2010.04.002     Document Type: Review

References (323)

1. Lawn J.E., Cousens S., Zupan J. 4 million neonatal deaths: when? Where? Why?. Lancet 2005, 365(9462):891-900.
2. Stoll B.J., Hansen N., Fanaroff A.A., et al. Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants. N Engl J Med 2002, 347(4):240-247.
3. Stoll B.J., Hansen N., Fanaroff A.A., et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics 2002, 110(2 Pt 1):285-291.
4. Stoll B.J., Hansen N.I., Higgins R.D., et al. Very low birth weight preterm infants with early onset neonatal sepsis: the predominance of Gram-negative infections continues in the National Institute of Child Health and Human Development Neonatal Research Network, 2002-2003. Pediatr Infect Dis J 2005, 24(7):635-639.
5. Haque K.N., Khan M.A., Kerry S., et al. Pattern of culture-proven neonatal sepsis in a district general hospital in the United Kingdom. Infect Control Hosp Epidemiol 2004, 25(9):759-764.
6. Haque K.N. Defining common infections in children and neonates. J Hosp Infect 2007, 65(Suppl 2):110-114.
7. Kermorvant-Duchemin E., Laborie S., Rabilloud M., et al. Outcome and prognostic factors in neonates with septic shock. Pediatr Crit Care Med 2008, 9(2):186-191.
8. Furman W.L., Menke J.A., Barson W.J., et al. Continuous naloxone infusion in two neonates with septic shock. J Pediatr 1984, 105(4):649-651.
9. Togari H., Mikawa M., Iwanaga T., et al. Endotoxin clearance by exchange blood transfusion in septic shock neonates. Acta Paediatr Scand 1983, 72(1):87-91.
10. Fenton L.J., Strunk R.C. Complement activation and group B streptococcal infection in the newborn: similarities to endotoxin shock. Pediatrics 1977, 60(6):901-907.
11. Tollner U., Pohlandt F. Septicemia in the newborn due to Gram-negative bacilli. Risk factors, clinical symptoms, and hematologic changes. Eur J Pediatr 1976, 123(4):243-254.
12. Frommhold D., Birle A., Linderkamp O., et al. Drotrecogin alpha (activated) in neonatal septic shock. Scand J Infect Dis 2005, 37(4):306-308.
13. Miyairi I., Berlingieri D., Protic J., et al. Neonatal invasive group A streptococcal disease: case report and review of the literature. Pediatr Infect Dis J 2004, 23(2):161-165.
14. Ahmed K., Sein P.P., Shahnawaz M., et al. Pasteurella gallinarum neonatal meningitis. Clin Microbiol Infect 2002, 8(1):55-57.
15. Roll C., Schmid E.N., Menken U., et al. Fatal Salmonella enteritidis sepsis acquired prenatally in a premature infant. Obstet Gynecol 1996, 88(4 Pt 2):692-693.
16. Wolfler A., Silvani P., Musicco M., et al. Incidence of and mortality due to sepsis, severe sepsis and septic shock in Italian Pediatric Intensive Care Units: a prospective national survey. Intensive Care Med 2008, 34(9):1690-1697.
17. Rodriguez-Nunez A., Lopez-Herce J., Gil-Anton J., et al. Rescue treatment with terlipressin in children with refractory septic shock: a clinical study. Crit Care 2006, 10(1):R20.
18. Tourneux P., Rakza T., Abazine A., et al. Noradrenaline for management of septic shock refractory to fluid loading and dopamine or dobutamine in full-term newborn infants. Acta Paediatr 2008, 97(2):177-180.
19. Filippi L., Poggi C., Serafini L., et al. Terlipressin as rescue treatment of refractory shock in a neonate. Acta Paediatr 2008, 97(4):500-502.
20. Meyer S., Loffler G., Polcher T., et al. Vasopressin in catecholamine-resistant septic and cardiogenic shock in very-low-birthweight infants. Acta Paediatr 2006, 95(10):1309-1312.
21. McAdams R.M., Garza-Cox S., Yoder B.A. Early-onset neonatal pneumococcal sepsis syndrome. Pediatr Crit Care Med 2005, 6(5):595-597.
22. Matok I., Leibovitch L., Vardi A., et al. Terlipressin as rescue therapy for intractable hypotension during neonatal septic shock. Pediatr Crit Care Med 2004, 5(2):116-118.
23. Aikio O., Vuopala K., Pokela M.L., et al. Diminished inducible nitric oxide synthase expression in fulminant early-onset neonatal pneumonia. Pediatrics 2000, 105(5):1013-1019.
24. Duke T.D., Butt W., South M. Predictors of mortality and multiple organ failure in children with sepsis. Intensive Care Med 1997, 23(6):684-692.
25. Goldstein B., Giroir B., Randolph A. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med 2005, 6(1):2-8.
26. Cayabyab R., McLean C.W., Seri I. Definition of hypotension and assessment of hemodynamics in the preterm neonate. J Perinatol 2009, 29(Suppl 2):S58-S62.
27. Shah G.S., Budhathoki S., Das B.K., et al. Risk factors in early neonatal sepsis. Kathmandu Univ Med J (KUMJ) 2006, 4(2):187-191.
28. Salem S.Y., Sheiner E., Zmora E., et al. Risk factors for early neonatal sepsis. Arch Gynecol Obstet 2006, 274(4):198-202.
29. Yancey M.K., Duff P., Kubilis P., et al. Risk factors for neonatal sepsis. Obstet Gynecol 1996, 87(2):188-194.
30. Benitz W.E., Gould J.B., Druzin M.L. Risk factors for early-onset group B streptococcal sepsis: estimation of odds ratios by critical literature review. Pediatrics 1999, 103(6):e77.
31. Fanaroff A.A., Korones S.B., Wright L.L., et al. Incidence, presenting features, risk factors and significance of late onset septicemia in very low birth weight infants. The National Institute of Child Health and Human Development Neonatal Research Network. Pediatr Infect Dis J 1998, 17(7):593-598.
32. Schuchat A., Zywicki S.S., Dinsmoor M.J., et al. Risk factors and opportunities for prevention of early-onset neonatal sepsis: a multicenter case-control study. Pediatrics 2000, 105(1 Pt 1):21-26.
33. Escobar G.J., Li D.K., Armstrong M.A., et al. Neonatal sepsis workups in infants >/=2000 grams at birth: a population-based study. Pediatrics 2000, 106(2 Pt 1):256-263.
34. Sharma R., Tepas J.J., Hudak M.L., et al. Neonatal gut barrier and multiple organ failure: role of endotoxin and proinflammatory cytokines in sepsis and necrotizing enterocolitis. J Pediatr Surg 2007, 42(3):454-461.
35. Sonntag J., Wagner M.H., Waldschmidt J., et al. Multisystem organ failure and capillary leak syndrome in severe necrotizing enterocolitis of very low birth weight infants. J Pediatr Surg 1998, 33(3):481-484.
36. Dahmer M.K., Randolph A., Vitali S., et al. Genetic polymorphisms in sepsis. Pediatr Crit Care Med 2005, 6(Suppl 3):S61-S73.
37. Cogulu O., Onay H., Uzunkaya D., et al. Role of angiotensin-converting enzyme gene polymorphisms in children with sepsis and septic shock. Pediatr Int 2008, 50(4):477-480.
38. Lyons E.J., Amos W., Berkley J.A., et al. Homozygosity and risk of childhood death due to invasive bacterial disease. BMC Med Genet 2009, 10:55.
39. Liangos O., Jaber B.L. Multiple organ dysfunction syndrome in children with sepsis: role of genetic factors. Semin Nephrol 2008, 28(5):499-509.
40. Kumpf O., Schumann R.R. Genetic influence on bloodstream infections and sepsis. Int J Antimicrob Agents 2008, 32(Suppl 1):S44-S50.
41. Sutherland A.M., Walley K.R. Bench-to-bedside review: association of genetic variation with sepsis. Crit Care 2009, 13(2):210.
42. Ahrens P., Kattner E., Kohler B., et al. Mutations of genes involved in the innate immune system as predictors of sepsis in very low birth weight infants. Pediatr Res 2004, 55(4):652-656.
43. Baier R.J., Loggins J., Yanamandra K. IL-10, IL-6 and CD14 polymorphisms and sepsis outcome in ventilated very low birth weight infants. BMC Med 2006, 4:10.
44. Chauhan M., McGuire W. Interleukin-6 (-174C) polymorphism and the risk of sepsis in very low birth weight infants: meta-analysis. Arch Dis Child Fetal Neonatal Ed 2008, 93(6):F427-F429.
45. Dzwonek A.B., Neth O.W., Thiebaut R., et al. The role of mannose-binding lectin in susceptibility to infection in preterm neonates. Pediatr Res 2008, 63(6):680-685.
46. Gopel W., Hartel C., Ahrens P., et al. Interleukin-6-174-genotype, sepsis and cerebral injury in very low birth weight infants. Genes Immun 2006, 7(1):65-68.
47. Hartel C., Rupp J., Hoegemann A., et al. 159C>T CD14 genotype-functional effects on innate immune responses in term neonates. Hum Immunol 2008, 69(6):338-343.
48. Hartel C., Schultz C., Herting E., et al. Genetic association studies in VLBW infants exemplifying susceptibility to sepsis-recent findings and implications for future research. Acta Paediatr 2007, 96(2):158-165.
49. Hubacek J.A., Stuber F., Frohlich D., et al. Gene variants of the bactericidal/permeability increasing protein and lipopolysaccharide binding protein in sepsis patients: gender-specific genetic predisposition to sepsis. Crit Care Med 2001, 29(3):557-561.
50. Mollen K.P., Gribar S.C., Anand R.J., et al. Increased expression and internalization of the endotoxin coreceptor CD14 in enterocytes occur as an early event in the development of experimental necrotizing enterocolitis. J Pediatr Surg 2008, 43(6):1175-1181.
51. Reiman M., Kujari H., Ekholm E., et al. Interleukin-6 polymorphism is associated with chorioamnionitis and neonatal infections in preterm infants. J Pediatr 2008, 153(1):19-24.
52. Schueller A.C., Heep A., Kattner E., et al. Prevalence of two tumor necrosis factor gene polymorphisms in premature infants with early onset sepsis. Biol Neonate 2006, 90(4):229-232.
53. Treszl A., Heninger E., Kalman A., et al. Lower prevalence of IL-4 receptor alpha-chain gene G variant in very-low-birth-weight infants with necrotizing enterocolitis. J Pediatr Surg 2003, 38(9):1374-1378.
54. Treszl A., Kocsis I., Szathmari M., et al. Genetic variants of TNF-[FC12]a, IL-1beta, IL-4 receptor [FC12]a-chain, IL-6 and IL-10 genes are not risk factors for sepsis in low-birth-weight infants. Biol Neonate 2003, 83(4):241-245.
55. Treszl A., Kocsis I., Szathmari M., et al. Genetic variants of the tumour necrosis factor-alpha promoter gene do not influence the development of necrotizing enterocolitis. Acta Paediatr 2001, 90(10):1182-1185.
56. Treszl A., Tulassay T., Vasarhelyi B. Genetic basis for necrotizing enterocolitis-risk factors and their relations to genetic polymorphisms. Front Biosci 2006, 11:570-580.
57. Verboon-Maciolek M.A., Krediet T.G., Gerards L.J., et al. Clinical and epidemiologic characteristics of viral infections in a neonatal intensive care unit during a 12-year period. Pediatr Infect Dis J 2005, 24(10):901-904.
58. Verboon-Maciolek M.A., Krediet T.G., Gerards L.J., et al. Severe neonatal parechovirus infection and similarity with enterovirus infection. Pediatr Infect Dis J 2008, 27(3):241-245.
59. Kawada J., Kimura H., Ito Y., et al. Evaluation of systemic inflammatory responses in neonates with herpes simplex virus infection. J Infect Dis 2004, 190(3):494-498.
60. Karlowicz M.G., Buescher E.S., Surka A.E. Fulminant late-onset sepsis in a neonatal intensive care unit, 1988-1997, and the impact of avoiding empiric vancomycin therapy. Pediatrics 2000, 106(6):1387-1390.
61. Hyde T.B., Hilger T.M., Reingold A., et al. Trends in incidence and antimicrobial resistance of early-onset sepsis: population-based surveillance in San Francisco and Atlanta. Pediatrics 2002, 110(4):690-695.
62. Benjamin D.K., DeLong E., Cotten C.M., et al. Mortality following blood culture in premature infants: increased with Gram-negative bacteremia and candidemia, but not Gram-positive bacteremia. J Perinatol 2004, 24(3):175-180.
63. Benjamin D.K., Stoll B.J., Fanaroff A.A., et al. Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months. Pediatrics 2006, 117(1):84-92.
64. Schelonka R.L., Chai M.K., Yoder B.A., et al. Volume of blood required to detect common neonatal pathogens. J Pediatr 1996, 129(2):275-278.
65. Kawai T., Akira S. The roles of TLRs, RLRs and NLRs in pathogen recognition. Int Immunol 2009, 21(4):317-337.
66. Kumagai Y., Takeuchi O., Akira S. Pathogen recognition by innate receptors. J Infect Chemother 2008, 14(2):86-92.
67. Trinchieri G., Sher A. Cooperation of Toll-like receptor signals in innate immune defence. Nat Rev Immunol 2007, 7(3):179-190.
68. Rittirsch D., Flierl M.A., Ward P.A. Harmful molecular mechanisms in sepsis. Nat Rev Immunol 2008, 8(10):776-787.
69. Krumbiegel D., Zepp F., Meyer C.U. Combined Toll-like receptor agonists synergistically increase production of inflammatory cytokines in human neonatal dendritic cells. Hum Immunol 2007, 68(10):813-822.
70. Bochud P.Y., Chien J.W., Marr K.A., et al. Toll-like receptor 4 polymorphisms and aspergillosis in stem-cell transplantation. N Engl J Med 2008, 359(17):1766-1777.
71. Wurfel M.M., Gordon A.C., Holden T.D., et al. Toll-like receptor 1 polymorphisms affect innate immune responses and outcomes in sepsis. Am J Respir Crit Care Med 2008, 178(7):710-720.
72. Agnese D.M., Calvano J.E., Hahm S.J., et al. Human toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of Gram-negative infections. J Infect Dis 2002, 186(10):1522-1525.
73. Lorenz E., Mira J.P., Cornish K.L., et al. A novel polymorphism in the toll-like receptor 2 gene and its potential association with staphylococcal infection. Infect Immun 2000, 68(11):6398-6401.
74. Zhang S.Y., Jouanguy E., Ugolini S., et al. TLR3 deficiency in patients with herpes simplex encephalitis. Science 2007, 317(5844):1522-1527.
75. Mockenhaupt F.P., Cramer J.P., Hamann L., et al. Toll-like receptor (TLR) polymorphisms in African children: common TLR-4 variants predispose to severe malaria. J Commun Dis 2006, 38(3):230-245.
76. Faber J., Meyer C.U., Gemmer C., et al. Human toll-like receptor 4 mutations are associated with susceptibility to invasive meningococcal disease in infancy. Pediatr Infect Dis J 2006, 25(1):80-81.
77. Zhang J.P., Chen C., Yang Y. Zhonghua Er Ke Za Zhi 2007, 45(2):130-133. [in Chinese].
78. Leaphart C.L., Cavallo J., Gribar S.C., et al. A critical role for TLR4 in the pathogenesis of necrotizing enterocolitis by modulating intestinal injury and repair. J Immunol 2007, 179(7):4808-4820.
79. Goldbach-Mansky R., Dailey N.J., Canna S.W., et al. Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition. N Engl J Med 2006, 355(6):581-592.
80. Szebeni B., Szekeres R., Rusai K., et al. Genetic polymorphisms of CD14, toll-like receptor 4, and caspase-recruitment domain 15 are not associated with necrotizing enterocolitis in very low birth weight infants. J Pediatr Gastroenterol Nutr 2006, 42(1):27-31.
81. Shigemoto T., Kageyama M., Hirai R., et al. Identification of loss of function mutations in human genes encoding RIG-I and mda5: implications for resistance to type I diabetes. J Biol Chem 2009, 284(20):13348-13354.
82. Warren S.E., Mao D.P., Rodriguez A.E., et al. Multiple Nod-like receptors activate caspase 1 during Listeria monocytogenes infection. J Immunol 2008, 180(11):7558-7564.
83. Behrendt D., Dembinski J., Heep A., et al. Lipopolysaccharide binding protein in preterm infants. Arch Dis Child Fetal Neonatal Ed 2004, 89(6):F551-F554.
84. Berner R., Furll B., Stelter F., et al. Elevated levels of lipopolysaccharide-binding protein and soluble CD14 in plasma in neonatal early-onset sepsis. Clin Diagn Lab Immunol 2002, 9(2):440-445.
85. Blanco A., Solis G., Arranz E., et al. Serum levels of CD14 in neonatal sepsis by Gram-positive and Gram-negative bacteria. Acta Paediatr 1996, 85(6):728-732.
86. Gu W., Shan Y.A., Zhou J., et al. Functional significance of gene polymorphisms in the promoter of myeloid differentiation-2. Ann Surg 2007, 246(1):151-158.
87. von Bernuth H., Picard C., Jin Z., et al. Pyogenic bacterial infections in humans with MyD88 deficiency. Science 2008, 321(5889):691-696.
88. Picard C., Puel A., Bonnet M., et al. Pyogenic bacterial infections in humans with IRAK-4 deficiency. Science 2003, 299(5615):2076-2079.
89. Ku C.L., Picard C., Erdos M., et al. IRAK4 and NEMO mutations in otherwise healthy children with recurrent invasive pneumococcal disease. J Med Genet 2007, 44(1):16-23.
90. Lotze M.T., Tracey K.J. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol 2005, 5(4):331-342.
91. Mullins G.E., Sunden-Cullberg J., Johansson A.S., et al. Activation of human umbilical vein endothelial cells leads to relocation and release of high-mobility group box chromosomal protein 1. Scand J Immunol 2004, 60(6):566-573.
92. van Zoelen M.A., Yang H., Florquin S., et al. Role of toll-like receptors 2 and 4, and the receptor for advanced glycation end products in high-mobility group box 1-induced inflammation in vivo. Shock 2009, 31(3):280-284.
93. Sappington P.L., Yang R., Yang H., et al. HMGB1 B box increases the permeability of Caco-2 enterocytic monolayers and impairs intestinal barrier function in mice. Gastroenterology 2002, 123(3):790-802.
94. Zamora R., Grishin A., Wong C., et al. High-mobility group box 1 protein is an inflammatory mediator in necrotizing enterocolitis: protective effect of the macrophage deactivator semapimod. Am J Physiol Gastrointest Liver Physiol 2005, 289(4):G643-G652.
95. Pack C.D., Kumaraguru U., Suvas S., et al. Heat-shock protein 70 acts as an effective adjuvant in neonatal mice and confers protection against challenge with herpes simplex virus. Vaccine 2005, 23(27):3526-3534.
96. Wheeler D.S., Lahni P., Odoms K., et al. Extracellular heat shock protein 60 (Hsp60) levels in children with septic shock. Inflamm Res 2007, 56(5):216-219.
97. Wheeler D.S., Fisher L.E., Catravas J.D., et al. Extracellular hsp70 levels in children with septic shock. Pediatr Crit Care Med 2005, 6(3):308-311.
98. Kono H., Rock K.L. How dying cells alert the immune system to danger. Nat Rev Immunol 2008, 8(4):279-289.
99. Batra S., Kumar R., Seema, et al. Alterations in antioxidant status during neonatal sepsis. Ann Trop Paediatr 2000, 20(1):27-33.
100. Kapoor K., Basu S., Das B.K., et al. Lipid peroxidation and antioxidants in neonatal septicemia. J Trop Pediatr 2006, 52(5):372-375.
101. Ng P.C. Diagnostic markers of infection in neonates. Arch Dis Child Fetal Neonatal Ed 2004, 89(3):F229-F235.
102. Ng P.C., Li K., Wong R.P., et al. Proinflammatory and anti-inflammatory cytokine responses in preterm infants with systemic infections. Arch Dis Child Fetal Neonatal Ed 2003, 88(3):F209-F213.
103. Levy O., Zarember K.A., Roy R.M., et al. Selective impairment of TLR-mediated innate immunity in human newborns: neonatal blood plasma reduces monocyte TNF-alpha induction by bacterial lipopeptides, lipopolysaccharide, and imiquimod, but preserves the response to R-848. J Immunol 2004, 173(7):4627-4634.
104. Bozza F.A., Salluh J.I., Japiassu A.M., et al. Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis. Crit Care 2007, 11(2):R49.
105. Hodge G., Hodge S., Haslam R., et al. Rapid simultaneous measurement of multiple cytokines using 100 microl sample volumes-association with neonatal sepsis. Clin Exp Immunol 2004, 137(2):402-407.
106. Heper Y., Akalin E.H., Mistik R., et al. Evaluation of serum C-reactive protein, procalcitonin, tumor necrosis factor alpha, and interleukin-10 levels as diagnostic and prognostic parameters in patients with community-acquired sepsis, severe sepsis, and septic shock. Eur J Clin Microbiol Infect Dis 2006, 25(8):481-491.
107. Atici A., Satar M., Cetiner S., et al. Serum tumor necrosis factor-alpha in neonatal sepsis. Am J Perinatol 1997, 14(7):401-404.
108. Sadeghi K., Berger A., Langgartner M., et al. Immaturity of infection control in preterm and term newborns is associated with impaired toll-like receptor signaling. J Infect Dis 2007, 195(2):296-302.
109. Kingsmore S.F., Kennedy N., Halliday H.L., et al. Identification of diagnostic biomarkers for infection in premature neonates. Mol Cell Proteomics 2008, 7(10):1863-1875.
110. Grobmyer S.R., Lin E., Lowry S.F., et al. Elevation of IL-18 in human sepsis. J Clin Immunol 2000, 20(3):212-215.
111. Hirata J., Kotani J., Aoyama M., et al. A role for IL-18 in human neutrophil apoptosis. Shock 2008, 30(6):628-633.
112. Cusumano V., Midiri A., Cusumano V.V., et al. Interleukin-18 is an essential element in host resistance to experimental group B streptococcal disease in neonates. Infect Immun 2004, 72(1):295-300.
113. Puren A.J., Fantuzzi G., Gu Y., et al. Interleukin-18 (IFNgamma-inducing factor) induces IL-8 and IL-1beta via TNFalpha production from non-CD14+ human blood mononuclear cells. J Clin Invest 1998, 101(3):711-721.
114. Elbim C., Guichard C., Dang P.M., et al. Interleukin-18 primes the oxidative burst of neutrophils in response to formyl-peptides: role of cytochrome b558 translocation and N-formyl peptide receptor endocytosis. Clin Diagn Lab Immunol 2005, 12(3):436-446.
115. Dollner H., Vatten L., Austgulen R. Early diagnostic markers for neonatal sepsis: comparing C-reactive protein, interleukin-6, soluble tumour necrosis factor receptors and soluble adhesion molecules. J Clin Epidemiol 2001, 54(12):1251-1257.
116. Turunen R., Andersson S., Nupponen I., et al. Increased CD11b-density on circulating phagocytes as an early sign of late-onset sepsis in extremely low-birth-weight infants. Pediatr Res 2005, 57(2):270-275.
117. Figueras-Aloy J., Gomez-Lopez L., Rodriguez-Miguelez J.M., et al. Serum soluble ICAM-1, VCAM-1, L-selectin, and P-selectin levels as markers of infection and their relation to clinical severity in neonatal sepsis. Am J Perinatol 2007, 24(6):331-338.
118. Kourtis A.P., Lee F.K., Stoll B.J. Soluble L-selectin, a marker of immune activation, in neonatal infection. Clin Immunol 2003, 109(2):224-228.
119. McEvoy L.T., Zakem-Cloud H., Tosi M.F. Total cell content of CR3 (CD11b/CD18) and LFA-1 (CD11a/CD18) in neonatal neutrophils: relationship to gestational age. Blood 1996, 87(9):3929-3933.
120. Buhrer C., Graulich J., Stibenz D., et al. L-selectin is down-regulated in umbilical cord blood granulocytes and monocytes of newborn infants with acute bacterial infection. Pediatr Res 1994, 36(6):799-804.
121. Sullivan S.E., Staba S.L., Gersting J.A., et al. Circulating concentrations of chemokines in cord blood, neonates, and adults. Pediatr Res 2002, 51(5):653-657.
122. Anderson D.C., Rothlein R., Marlin S.D., et al. Impaired transendothelial migration by neonatal neutrophils: abnormalities of Mac-1 (CD11b/CD18)-dependent adherence reactions. Blood 1990, 76(12):2613-2621.
123. Meade V.M., Barese C.N., Kim C., et al. Rac2 concentrations in umbilical cord neutrophils. Biol Neonate 2006, 90(3):156-159.
124. Hickey M.J., Kubes P. Intravascular immunity: the host-pathogen encounter in blood vessels. Nat Rev Immunol 2009, 9(5):364-375.
125. Ng P.C., Li K., Chui K.M., et al. IP-10 is an early diagnostic marker for identification of late-onset bacterial infection in preterm infants. Pediatr Res 2007, 61(1):93-98.
126. Wong H.R., Cvijanovich N., Wheeler D.S., et al. Interleukin-8 as a stratification tool for interventional trials involving pediatric septic shock. Am J Respir Crit Care Med 2008, 178(3):276-282.
127. Ng P.C., Li K., Leung T.F., et al. Early prediction of sepsis-induced disseminated intravascular coagulation with interleukin-10, interleukin-6, and RANTES in preterm infants. Clin Chem 2006, 52(6):1181-1189.
128. Sriskandan S., Altmann D.M. The immunology of sepsis. J Pathol 2008, 214(2):211-223.
129. Hartel C., Osthues I., Rupp J., et al. Characterisation of the host inflammatory response to Staphylococcus epidermidis in neonatal whole blood. Arch Dis Child Fetal Neonatal Ed 2008, 93(2):F140-F145.
130. Sikora J.P., Chlebna-Sokol D., Krzyzanska-Oberbek A. Proinflammatory cytokines (IL-6, IL-8), cytokine inhibitors (IL-6sR, sTNFRII) and anti-inflammatory cytokines (IL-10, IL-13) in the pathogenesis of sepsis in newborns and infants. Arch Immunol Ther Exp (Warsz) 2001, 49(5):399-404.
131. Opal S.M., Esmon C.T. Bench-to-bedside review: functional relationships between coagulation and the innate immune response and their respective roles in the pathogenesis of sepsis. Crit Care 2003, 7(1):23-38.
132. Wang P., Wu P., Siegel M.I., et al. Interleukin (IL)-10 inhibits nuclear factor kappa B (NF kappa B) activation in human monocytes. IL-10 and IL-4 suppress cytokine synthesis by different mechanisms. J Biol Chem 1995, 270(16):9558-9563.
133. Brubaker J.O., Montaner L.J. Role of interleukin-13 in innate and adaptive immunity. Cell Mol Biol (Noisy-le-grand) 2001, 47(4):637-651.
134. Trepicchio W.L., Bozza M., Pedneault G., et al. Recombinant human IL-11 attenuates the inflammatory response through down-regulation of proinflammatory cytokine release and nitric oxide production. J Immunol 1996, 157(8):3627-3634.
135. Koj A. Termination of acute-phase response: role of some cytokines and anti-inflammatory drugs. Gen Pharmacol 1998, 31(1):9-18.
136. Spear M.L., Stefano J.L., Fawcett P., et al. Soluble interleukin-2 receptor as a predictor of neonatal sepsis. J Pediatr 1995, 126(6):982-985.
137. Dollner H., Vatten L., Linnebo I., et al. Inflammatory mediators in umbilical plasma from neonates who develop early-onset sepsis. Biol Neonate 2001, 80(1):41-47.
138. Buhimschi C.S., Bhandari V., Han Y.W., et al. Using proteomics in perinatal and neonatal sepsis: hopes and challenges for the future. Curr Opin Infect Dis 2009, 22(3):235-243.
139. Bopp C., Hofer S., Weitz J., et al. sRAGE is elevated in septic patients and associated with patients outcome. J Surg Res 2008, 147(1):79-83.
140. Liliensiek B., Weigand M.A., Bierhaus A., et al. Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response. J Clin Invest 2004, 113(11):1641-1650.
141. Wolach B., Dolfin T., Regev R., et al. The development of the complement system after 28 weeks' gestation. Acta Paediatr 1997, 86(5):523-527.
142. Notarangelo L.D., Chirico G., Chiara A., et al. Activity of classical and alternative pathways of complement in preterm and small for gestational age infants. Pediatr Res 1984, 18(3):281-285.
143. Drossou V., Kanakoudi F., Diamanti E., et al. Concentrations of main serum opsonins in early infancy. Arch Dis Child Fetal Neonatal Ed 1995, 72(3):F172-F175.
144. Miller M.E., Stiehm E.R. Phagocytic, opsonic and immunoglobulin studies in newborns. Calif Med 1973, 119(2):43-63.
145. Nupponen I., Andersson S., Jarvenpaa A.L., et al. Neutrophil CD11b expression and circulating interleukin-8 as diagnostic markers for early-onset neonatal sepsis. Pediatrics 2001, 108(1):E12.
146. Berger M., O'Shea J., Cross A.S., et al. Human neutrophils increase expression of C3bi as well as C3b receptors upon activation. J Clin Invest 1984, 74(5):1566-1571.
147. Snyderman R., Goetzl E.J. Molecular and cellular mechanisms of leukocyte chemotaxis. Science 1981, 213(4510):830-837.
148. Vogt W. Anaphylatoxins: possible roles in disease. Complement 1986, 3(3):177-188.
149. Ehlers M.R. CR3: a general purpose adhesion-recognition receptor essential for innate immunity. Microbes Infect 2000, 2(3):289-294.
150. Markiewski M.M., Lambris J.D. The role of complement in inflammatory diseases from behind the scenes into the spotlight. Am J Pathol 2007, 171(3):715-727.
151. Nybo M., Sorensen O., Leslie R., et al. Reduced expression of C5a receptors on neutrophils from cord blood. Arch Dis Child Fetal Neonatal Ed 1998, 78(2):F129-F132.
152. Lothian C., Dahlgren C., Lagercrantz H., et al. Different expression and mobilisation of the complement regulatory proteins CD35, CD55 and CD59 in neonatal and adult neutrophils. Biol Neonate 1997, 72(1):15-21.
153. Castellheim A., Lindenskov P.H., Pharo A., et al. Meconium aspiration syndrome induces complement-associated systemic inflammatory response in newborn piglets. Scand J Immunol 2005, 61(3):217-225.
154. Wong H.R., Doughty L.A., Wedel N., et al. Plasma bactericidal/permeability-increasing protein concentrations in critically ill children with the sepsis syndrome. Pediatr Infect Dis J 1995, 14(12):1087-1091.
155. Levy O. Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat Rev Immunol 2007, 7(5):379-390.
156. Levy O., Martin S., Eichenwald E., et al. Impaired innate immunity in the newborn: newborn neutrophils are deficient in bactericidal/permeability-increasing protein. Pediatrics 1999, 104(6):1327-1333.
157. Michalek J., Svetlikova P., Fedora M., et al. Bactericidal permeability increasing protein gene variants in children with sepsis. Intensive Care Med 2007, 33(12):2158-2164.
158. Dyke M.P., Forsyth K.D. Decreased plasma fibronectin concentrations in preterm infants with septicaemia. Arch Dis Child 1993, 68(5 Spec No):557-560.
159. Romeo M.G., Tina L.G., Sciacca A., et al. Pediatr Med Chir 1995, 17(6):563-566. [in Italian].
160. Kalayci A.G., Adam B., Yilmazer F., et al. The value of immunoglobulin and complement levels in the early diagnosis of neonatal sepsis. Acta Paediatr 1997, 86(9):999-1002.
161. Madden N.P., Levinsky R.J., Bayston R., et al. Surgery, sepsis, and nonspecific immune function in neonates. J Pediatr Surg 1989, 24(6):562-566.
162. Hathaway W.E., Mull M.M., Pechet G.S. Disseminated intravascular coagulation in the newborn. Pediatrics 1969, 43(2):233-240.
163. Kimberlin D.W., Lin C.Y., Jacobs R.F., et al. Natural history of neonatal herpes simplex virus infections in the acyclovir era. Pediatrics 2001, 108(2):223-229.
164. Rivers R.P., Cattermole H.E., Wright I. The expression of surface tissue factor apoprotein by blood monocytes in the course of infections in early infancy. Pediatr Res 1992, 31(6):567-573.
165. Markiewski M.M., Nilsson B., Ekdahl K.N., et al. Complement and coagulation: strangers or partners in crime?. Trends Immunol 2007, 28(4):184-192.
166. Aronis S., Platokouki H., Photopoulos S., et al. Indications of coagulation and/or fibrinolytic system activation in healthy and sick very-low-birth-weight neonates. Biol Neonate 1998, 74(5):337-344.
167. Lauterbach R., Pawlik D., Radziszewska R., et al. Plasma antithrombin III and protein C levels in early recognition of late-onset sepsis in newborns. Eur J Pediatr 2006, 165(9):585-589.
168. Roman J., Velasco F., Fernandez F., et al. Coagulation, fibrinolytic and kallikrein systems in neonates with uncomplicated sepsis and septic shock. Haemostasis 1993, 23(3):142-148.
169. Venkataseshan S., Dutta S., Ahluwalia J., et al. Low plasma protein C values predict mortality in low birth weight neonates with septicemia. Pediatr Infect Dis J 2007, 26(8):684-688.
170. Sola M.C., Del Vecchio A., Rimsza L.M. Evaluation and treatment of thrombocytopenia in the neonatal intensive care unit. Clin Perinatol 2000, 27(3):655-679.
171. Guida J.D., Kunig A.M., Leef K.H., et al. Platelet count and sepsis in very low birth weight neonates: is there an organism-specific response?. Pediatrics 2003, 111(6 Pt 1):1411-1415.
172. Finkelstein Y., Shenkman B., Sirota L., et al. Whole blood platelet deposition on extracellular matrix under flow conditions in preterm neonatal sepsis. Eur J Pediatr 2002, 161(5):270-274.
173. Bednarek F.J., Bean S., Barnard M.R., et al. The platelet hyporeactivity of extremely low birth weight neonates is age-dependent. Thromb Res 2009, 124(1):42-45.
174. Urlichs F., Speer C. Neutrophil function in preterm and term infants. Neoreviews 2004, 5:e417-e430.
175. Marodi L. Innate cellular immune responses in newborns. Clin Immunol 2006, 118(2-3):137-144.
176. Christensen R.D., Rothstein G. Exhaustion of mature marrow neutrophils in neonates with sepsis. J Pediatr 1980, 96(2):316-318.
177. Engle W.A., McGuire W.A., Schreiner R.L., et al. Neutrophil storage pool depletion in neonates with sepsis and neutropenia. J Pediatr 1988, 113(4):747-749.
178. Sarkar S., Bhagat I., Hieber S., et al. Can neutrophil responses in very low birth weight infants predict the organisms responsible for late-onset bacterial or fungal sepsis?. J Perinatol 2006, 26(8):501-505.
179. Christensen R.D., Bradley P.P., Rothstein G. The leukocyte left shift in clinical and experimental neonatal sepsis. J Pediatr 1981, 98(1):101-105.
180. Drossou V., Kanakoudi F., Tzimouli V., et al. Impact of prematurity, stress and sepsis on the neutrophil respiratory burst activity of neonates. Biol Neonate 1997, 72(4):201-209.
181. Shigeoka A.O., Santos J.I., Hill H.R. Functional analysis of neutrophil granulocytes from healthy, infected, and stressed neonates. J Pediatr 1979, 95(3):454-460.
182. Wright W.C., Ank B.J., Herbert J., et al. Decreased bactericidal activity of leukocytes of stressed newborn infants. Pediatrics 1975, 56(4):579-584.
183. Linderkamp O., Ruef P., Brenner B., et al. Passive deformability of mature, immature, and active neutrophils in healthy and septicemic neonates. Pediatr Res 1998, 44(6):946-950.
184. Mease A.D., Burgess D.P., Thomas P.J. Irreversible neutrophil aggregation. A mechanism of decreased newborn neutrophil chemotactic response. Am J Pathol 1981, 104(1):98-102.
185. Ohman L., Tullus K., Katouli M., et al. Correlation between susceptibility of infants to infections and interaction with neutrophils of Escherichia coli strains causing neonatal and infantile septicemia. J Infect Dis 1995, 171(1):128-133.
186. Allgaier B., Shi M., Luo D., et al. Spontaneous and Fas-mediated apoptosis are diminished in umbilical cord blood neutrophils compared with adult neutrophils. J Leukoc Biol 1998, 64(3):331-336.
187. Hanna N., Vasquez P., Pham P., et al. Mechanisms underlying reduced apoptosis in neonatal neutrophils. Pediatr Res 2005, 57(1):56-62.
188. Koenig J.M., Stegner J.J., Schmeck A.C., et al. Neonatal neutrophils with prolonged survival exhibit enhanced inflammatory and cytotoxic responsiveness. Pediatr Res 2005, 57(3):424-429.
189. Nupponen I., Pesonen E., Andersson S., et al. Neutrophil activation in preterm infants who have respiratory distress syndrome. Pediatrics 2002, 110(1 Pt 1):36-41.
190. Nathan C.F. Secretory products of macrophages. J Clin Invest 1987, 79(2):319-326.
191. Hodge G., Hodge S., Han P., et al. Multiple leucocyte activation markers to detect neonatal infection. Clin Exp Immunol 2004, 135(1):125-129.
192. Georgeson G.D., Szony B.J., Streitman K., et al. Natural killer cell cytotoxicity is deficient in newborns with sepsis and recurrent infections. Eur J Pediatr 2001, 160(8):478-482.
193. el-Sameea E.R., Metwally S.S., Mashhour E., et al. Evaluation of natural killer cells as diagnostic markers of early onset neonatal sepsis: comparison with C-reactive protein and interleukin-8. Egypt J Immunol 2004, 11(1):91-102.
194. Mazur B., Godula-Stuglik U., Domarecki A., et al. Ginekol Pol 2000, 71(6):542-549. [in Polish].
195. Marshall J.S., Jawdat D.M. Mast cells in innate immunity. J Allergy Clin Immunol 2004, 114(1):21-27.
196. von Kockritz-Blickwede M., Goldmann O., Thulin P., et al. Phagocytosis-independent antimicrobial activity of mast cells by means of extracellular trap formation. Blood 2008, 111(6):3070-3080.
197. Mazzoni A., Young H.A., Spitzer J.H., et al. Histamine regulates cytokine production in maturing dendritic cells, resulting in altered T cell polarization. J Clin Invest 2001, 108(12):1865-1873.
198. Damsgaard T.E., Nielsen B.W., Henriques U., et al. Histamine releasing cells of the newborn. Mast cells from the umbilical cord matrix and basophils from cord blood. Pediatr Allergy Immunol 1996, 7(2):83-90.
199. Schneider L.A., Schlenner S.M., Feyerabend T.B., et al. Molecular mechanism of mast cell mediated innate defense against endothelin and snake venom sarafotoxin. J Exp Med 2007, 204(11):2629-2639.
200. Peters K., Unger R.E., Brunner J., et al. Molecular basis of endothelial dysfunction in sepsis. Cardiovasc Res 2003, 60(1):49-57.
201. Marshall J.C. Such stuff as dreams are made on: mediator-directed therapy in sepsis. Nat Rev Drug Discov 2003, 2(5):391-405.
202. Marom D., Yuhas Y., Sirota L., et al. Nitric oxide levels in preterm and term infants and in premature infants with bacteremia. Biol Neonate 2004, 86(3):160-164.
203. Schrama A.J., de Beaufort A.J., Poorthuis B.J., et al. Secretory phospholipase A(2) in newborn infants with sepsis. J Perinatol 2008, 28(4):291-296.
204. Siauw C., Kobsar A., Dornieden C., et al. Group B streptococcus isolates from septic patients and healthy carriers differentially activate platelet signaling cascades. Thromb Haemost 2006, 95(5):836-849.
205. Figueras-Aloy J., Gomez-Lopez L., Rodriguez-Miguelez J.M., et al. Plasma endothelin-1 and clinical manifestations of neonatal sepsis. J Perinat Med 2004, 32(6):522-526.
206. Kuhl P.G., Cotton R.B., Schweer H., et al. Endogenous formation of prostanoids in neonates with persistent pulmonary hypertension. Arch Dis Child 1989, 64(7 Spec No):949-952.
207. Rosenberg A.A., Kennaugh J., Koppenhafer S.L., et al. Elevated immunoreactive endothelin-1 levels in newborn infants with persistent pulmonary hypertension. J Pediatr 1993, 123(1):109-114.
208. Rossi P., Persson B., Boels P.J., et al. Endotoxemic pulmonary hypertension is largely mediated by endothelin-induced venous constriction. Intensive Care Med 2008, 34(5):873-880.
209. Bulger E.M., Maier R.V. Lipid mediators in the pathophysiology of critical illness. Crit Care Med 2000, 28(Suppl 4):N27-N36.
210. Gotsch F., Romero R., Kusanovic J.P., et al. The fetal inflammatory response syndrome. Clin Obstet Gynecol 2007, 50(3):652-683.
211. Shi Y., Li H.Q., Shen C.K., et al. Plasma nitric oxide levels in newborn infants with sepsis. J Pediatr 1993, 123(3):435-438.
212. Kultursay N., Kantar M., Akisu M., et al. Platelet-activating factor concentrations in healthy and septic neonates. Eur J Pediatr 1999, 158(9):740-741.
213. Lopez A., Lorente J.A., Steingrub J., et al. Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock. Crit Care Med 2004, 32(1):21-30.
214. Nimah M., Brilli R.J. Coagulation dysfunction in sepsis and multiple organ system failure. Crit Care Clin 2003, 19(3):441-458.
215. Cribbs S.K., Martin G.S., Rojas M. Monitoring of endothelial dysfunction in critically ill patients: the role of endothelial progenitor cells. Curr Opin Crit Care 2008, 14(3):354-360.
216. Gibson R.L., Nizet V., Rubens C.E. Group B streptococcal beta-hemolysin promotes injury of lung microvascular endothelial cells. Pediatr Res 1999, 45(5 Pt 1):626-634.
217. Dakshinamurti S. Pathophysiologic mechanisms of persistent pulmonary hypertension of the newborn. Pediatr Pulmonol 2005, 39(6):492-503.
218. Arai H., Matsuda T., Goto R., et al. Increased numbers of macrophages in tracheal aspirates in premature infants with funisitis. Pediatr Int 2008, 50(2):184-188.
219. McKiernan C.A., Lieberman S.A. Circulatory shock in children: an overview. Pediatr Rev 2005, 26(12):451-460.
220. Luce W.A., Hoffman T.M., Bauer J.A. Bench-to-bedside review: developmental influences on the mechanisms, treatment and outcomes of cardiovascular dysfunction in neonatal versus adult sepsis. Crit Care 2007, 11(5):228.
221. Maeder M., Fehr T., Rickli H., et al. Sepsis-associated myocardial dysfunction: diagnostic and prognostic impact of cardiac troponins and natriuretic peptides. Chest 2006, 129(5):1349-1366.
222. Tabbutt S. Heart failure in pediatric septic shock: utilizing inotropic support. Crit Care Med 2001, 29(Suppl 10):S231-S236.
223. Ceneviva G., Paschall J.A., Maffei F., et al. Hemodynamic support in fluid-refractory pediatric septic shock. Pediatrics 1998, 102(2):e19.
224. Carcillo J.A., Fields A.I. Clinical practice parameters for hemodynamic support of pediatric and neonatal patients in septic shock. Crit Care Med 2002, 30(6):1365-1378.
225. Evans N. Which inotrope for which baby?. Arch Dis Child Fetal Neonatal Ed 2006, 91(3):F213-F220.
226. Kluckow M., Evans N. Relationship between blood pressure and cardiac output in preterm infants requiring mechanical ventilation. J Pediatr 1996, 129(4):506-512.
227. Seri I., Noori S. Diagnosis and treatment of neonatal hypotension outside the transitional period. Early Hum Dev 2005, 81(5):405-411.
228. Cochat P., Bourgeois J., Gilly J., et al. Pediatrie 1986, 41(1):7-15. [in French].
229. Csaicsich D., Russo-Schlaff N., Messerschmidt A., et al. Renal failure, comorbidity and mortality in preterm infants. Wien Klin Wochenschr 2008, 120(5-6):153-157.
230. Spapen H. Liver perfusion in sepsis, septic shock, and multiorgan failure. Anat Rec (Hoboken) 2008, 291(6):714-720.
231. Bhutta Z.A., Yusuf K. Neonatal sepsis in Karachi: factors determining outcome and mortality. J Trop Pediatr 1997, 43(2):65-70.
232. Faix R.G., Donn S.M. Association of septic shock caused by early-onset group B streptococcal sepsis and periventricular leukomalacia in the preterm infant. Pediatrics 1985, 76(3):415-419.
233. Harris M.C., D'Angio C.T., Gallagher P.R., et al. Cytokine elaboration in critically ill infants with bacterial sepsis, necrotizing entercolitis, or sepsis syndrome: correlation with clinical parameters of inflammation and mortality. J Pediatr 2005, 147(4):462-468.
234. Di Naro E., Cromi A., Ghezzi F., et al. Fetal thymic involution: a sonographic marker of the fetal inflammatory response syndrome. Am J Obstet Gynecol 2006, 194(1):153-159.
235. Cinel I., Dellinger R.P. Advances in pathogenesis and management of sepsis. Curr Opin Infect Dis 2007, 20(4):345-352.
236. Cinel I., Opal S.M. Molecular biology of inflammation and sepsis: a primer. Crit Care Med 2009, 37(1):291-304.
237. Pfenninger J., Tschaeppeler H., Wagner B.P., et al. The paradox of adult respiratory distress syndrome in neonates. Pediatr Pulmonol 1991, 10(1):18-24.
238. Engle W.A. Surfactant-replacement therapy for respiratory distress in the preterm and term neonate. Pediatrics 2008, 121(2):419-432.
239. Ng P.C., Lam C.W., Fok T.F., et al. Refractory hypotension in preterm infants with adrenocortical insufficiency. Arch Dis Child Fetal Neonatal Ed 2001, 84(2):F122-F124.
240. Das B.K., Agarwal P., Agarwal J.K., et al. Serum cortisol and thyroid hormone levels in neonates with sepsis. Indian J Pediatr 2002, 69(8):663-665.
241. Glavina-Durdov M., Springer O., Capkun V., et al. The grade of acute thymus involution in neonates correlates with the duration of acute illness and with the percentage of lymphocytes in peripheral blood smear. Pathological study. Biol Neonate 2003, 83(4):229-234.
242. Itoh K., Aihara H., Takada S., et al. Clinicopathological differences between early-onset and late-onset sepsis and pneumonia in very low birth weight infants. Pediatr Pathol 1990, 10(5):757-768.
243. Timens W., Boes A., Rozeboom-Uiterwijk T., et al. Immaturity of the human splenic marginal zone in infancy. Possible contribution to the deficient infant immune response. J Immunol 1989, 143(10):3200-3206.
244. Toti P., De Felice C., Occhini R., et al. Spleen depletion in neonatal sepsis and chorioamnionitis. Am J Clin Pathol 2004, 122(5):765-771.
245. Toti P., De Felice C., Stumpo M., et al. Acute thymic involution in fetuses and neonates with chorioamnionitis. Hum Pathol 2000, 31(9):1121-1128.
246. van Baarlen J., Schuurman H.J., Huber J. Acute thymus involution in infancy and childhood: a reliable marker for duration of acute illness. Hum Pathol 1988, 19(10):1155-1160.
247. Hotchkiss R.S., Coopersmith C.M., Karl I.E. Prevention of lymphocyte apoptosis-a potential treatment of sepsis?. Clin Infect Dis 2005, 41(Suppl 7):S465-S469.
248. Kalman L., Lindegren M.L., Kobrynski L., et al. Mutations in genes required for T-cell development: IL7R, CD45, IL2RG, JAK3, RAG1, RAG2, ARTEMIS, and ADA and severe combined immunodeficiency: HuGE review. Genet Med 2004, 6(1):16-26.
249. Le Tulzo Y., Pangault C., Gacouin A., et al. Early circulating lymphocyte apoptosis in human septic shock is associated with poor outcome. Shock 2002, 18(6):487-494.
250. Wynn J.L., Scumpia P.O., Winfield R.D., et al. Defective innate immunity predisposes murine neonates to poor sepsis outcome but is reversed by TLR agonists. Blood 2008, 112(5):1750-1758.
251. Bauer J., Hentschel R., Linderkamp O. Effect of sepsis syndrome on neonatal oxygen consumption and energy expenditure. Pediatrics 2002, 110(6):e69.
252. Romeo C., Eaton S., Spitz L., et al. Nitric oxide inhibits neonatal hepatocyte oxidative metabolism. J Pediatr Surg 2000, 35(1):44-48.
253. Eaton S. Impaired energy metabolism during neonatal sepsis: the effects of glutamine. Proc Nutr Soc 2003, 62(3):745-751.
254. Dellinger R.P., Levy M.M., Carlet J.M., et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med 2008, 34(1):17-60.
255. Brierley J., Carcillo J.A., Choong K., et al. Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock: 2007 update from the American College of Critical Care Medicine. Crit Care Med 2009, 37(2):666-688.
256. Parker M.M., Hazelzet J.A., Carcillo J.A. Pediatric considerations. Crit Care Med 2004, 32(Suppl 11):S591-S594.
257. Dempsey E.M., Al Hazzani F., Barrington K.J. Permissive hypotension in the extremely low birthweight infant with signs of good perfusion. Arch Dis Child Fetal Neonatal Ed 2009, 94(4):F241-F244.
258. Shiao S.Y. Effects of fetal hemoglobin on accurate measurements of oxygen saturation in neonates. J Perinat Neonatal Nurs 2005, 19(4):348-361.
259. Kluckow M., Seri I., Evans N. Echocardiography and the neonatologist. Pediatr Cardiol 2008, 29(6):1043-1047.
260. Kluckow M., Seri I., Evans N. Functional echocardiography: an emerging clinical tool for the neonatologist. J Pediatr 2007, 150(2):125-130.
261. Evans N., Kluckow M., Simmons M., et al. Which to measure, systemic or organ blood flow? Middle cerebral artery and superior vena cava flow in very preterm infants. Arch Dis Child Fetal Neonatal Ed 2002, 87(3):F181-F184.
262. Kluckow M., Evans N. Superior vena cava flow in newborn infants: a novel marker of systemic blood flow. Arch Dis Child Fetal Neonatal Ed 2000, 82(3):F182-F187.
263. Hunt R.W., Evans N., Rieger I., et al. Low superior vena cava flow and neurodevelopment at 3 years in very preterm infants. J Pediatr 2004, 145(5):588-592.
264. Miletin J., Pichova K., Dempsey E.M. Bedside detection of low systemic flow in the very low birth weight infant on day 1 of life. Eur J Pediatr 2009, 168(7):809-813.
265. Fortune P.M., Wagstaff M., Petros A.J. Cerebro-splanchnic oxygenation ratio (CSOR) using near infrared spectroscopy may be able to predict splanchnic ischaemia in neonates. Intensive Care Med 2001, 27(8):1401-1407.
266. Johnson B.A., Hoffman G.M., Tweddell J.S., et al. Near-infrared spectroscopy in neonates before palliation of hypoplastic left heart syndrome. Ann Thorac Surg 2009, 87(2):571-577. [discussion: 577-9].
267. Osborn D.A., Evans N., Kluckow M., et al. Low superior vena cava flow and effect of inotropes on neurodevelopment to 3 years in preterm infants. Pediatrics 2007, 120(2):372-380.
268. Seri I. Circulatory support of the sick preterm infant. Semin Neonatol 2001, 6(1):85-95.
269. Munro M.J., Walker A.M., Barfield C.P. Hypotensive extremely low birth weight infants have reduced cerebral blood flow. Pediatrics 2004, 114(6):1591-1596.
270. Han Y.Y., Carcillo J.A., Dragotta M.A., et al. Early reversal of pediatric-neonatal septic shock by community physicians is associated with improved outcome. Pediatrics 2003, 112(4):793-799.
271. Osborn D.A., Evans N. Early volume expansion for prevention of morbidity and mortality in very preterm infants [review]. Cochrane Database Syst Rev 2004, 2:CD002055.
272. Goldberg R.N., Chung D., Goldman S.L., et al. The association of rapid volume expansion and intraventricular hemorrhage in the preterm infant. J Pediatr 1980, 96(6):1060-1063.
273. Pellicer A., Valverde E., Elorza M.D., et al. Cardiovascular support for low birth weight infants and cerebral hemodynamics: a randomized, blinded, clinical trial. Pediatrics 2005, 115(6):1501-1512.
274. Osborn D., Evans N., Kluckow M. Randomized trial of dobutamine versus dopamine in preterm infants with low systemic blood flow. J Pediatr 2002, 140(2):183-191.
275. Osborn D.A., Paradisis M., Evans N. The effect of inotropes on morbidity and mortality in preterm infants with low systemic or organ blood flow [review]. Cochrane Database Syst Rev 2007, 1:CD005090.
276. Barton P., Garcia J., Kouatli A., et al. Hemodynamic effects of i.v. milrinone lactate in pediatric patients with septic shock. A prospective, double-blinded, randomized, placebo-controlled, interventional study. Chest 1996, 109(5):1302-1312.
277. Paradisis M., Evans N., Kluckow M., et al. Randomized trial of milrinone versus placebo for prevention of low systemic blood flow in very preterm infants. J Pediatr 2009, 154(2):189-195.
278. Leone M., Martin C. Role of terlipressin in the treatment of infants and neonates with catecholamine-resistant septic shock. Best Pract Res Clin Anaesthesiol 2008, 22(2):323-333.
279. Meyer S., Gottschling S., Baghai A., et al. Arginine-vasopressin in catecholamine-refractory septic versus non-septic shock in extremely low birth weight infants with acute renal injury. Crit Care 2006, 10(3):R71.
280. Annane D., Bellissant E., Bollaert P.E., et al. Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis. BMJ 2004, 329(7464):480.
281. Annane D., Sebille V., Charpentier C., et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002, 288(7):862-871.
282. Sprung C.L., Annane D., Keh D., et al. Hydrocortisone therapy for patients with septic shock. N Engl J Med 2008, 358(2):111-124.
283. Togari H., Sugiyama S., Ogino T., et al. Interactions of endotoxin with cortisol and acute phase proteins in septic shock neonates. Acta Paediatr Scand 1986, 75(1):69-74.
284. Seri I., Tan R., Evans J. Cardiovascular effects of hydrocortisone in preterm infants with pressor-resistant hypotension. Pediatrics 2001, 107(5):1070-1074.
285. Noori S., Friedlich P., Wong P., et al. Hemodynamic changes after low-dosage hydrocortisone administration in vasopressor-treated preterm and term neonates. Pediatrics 2006, 118(4):1456-1466.
286. Fernandez E.F., Watterberg K.L. Relative adrenal insufficiency in the preterm and term infant. J Perinatol 2009, 29(Suppl 2):S44-S49.
287. Roberts J.D., Fineman J.R., Morin F.C., et al. Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. The Inhaled Nitric Oxide Study Group. N Engl J Med 1997, 336(9):605-610.
288. Farrow K.N., Fliman P., Steinhorn R.H. The diseases treated with ECMO: focus on PPHN. Semin Perinatol 2005, 29(1):8-14.
289. Maclaren G., Butt W. Extracorporeal membrane oxygenation and sepsis. Crit Care Resusc 2007, 9(1):76-80.
290. Shankaran S., Laptook A.R., Ehrenkranz R.A., et al. Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy. N Engl J Med 2005, 353(15):1574-1584.
291. Emery E.F., Greenough A., Gamsu H.R. Randomised controlled trial of colloid infusions in hypotensive preterm infants. Arch Dis Child 1992, 67(10 Spec No):1185-1188.
292. Neu J., Huang Y. Nutrition of premature and critically ill neonates. Nestle Nutr Workshop Ser Clin Perform Programme 2003, 8:171-181. [discussion: 181-5].
293. Park W., Paust H., Schroder H. Lipid infusion in premature infants suffering from sepsis. JPEN J Parenter Enteral Nutr 1984, 8(3):290-292.
294. Toce S.S., Keenan W.J. Lipid intolerance in newborns is associated with hepatic dysfunction but not infection. Arch Pediatr Adolesc Med 1995, 149(11):1249-1253.
295. Basu R., Muller D.P., Eaton S., et al. Lipid peroxidation can be reduced in infants on total parenteral nutrition by promoting fat utilisation. J Pediatr Surg 1999, 34(2):255-259.
296. Pierro A. Metabolism and nutritional support in the surgical neonate. J Pediatr Surg 2002, 37(6):811-822.
297. Mathur N.B., Singh A., Sharma V.K., et al. Evaluation of risk factors for fatal neonatal sepsis. Indian Pediatr 1996, 33(10):817-822.
298. Adams-Chapman I., Stoll B.J. Neonatal infection and long-term neurodevelopmental outcome in the preterm infant. Curr Opin Infect Dis 2006, 19(3):290-297.
299. Stoll B.J., Hansen N.I., Adams-Chapman I., et al. Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA 2004, 292(19):2357-2365.
300. Bassler D., Stoll B.J., Schmidt B., et al. Using a count of neonatal morbidities to predict poor outcome in extremely low birth weight infants: added role of neonatal infection. Pediatrics 2009, 123(1):313-318.
301. Shah D.K., Doyle L.W., Anderson P.J., et al. Adverse neurodevelopment in preterm infants with postnatal sepsis or necrotizing enterocolitis is mediated by white matter abnormalities on magnetic resonance imaging at term. J Pediatr 2008, 153(2):170-175. 175 e171.
302. Hintz S.R., Kendrick D.E., Stoll B.J., et al. Neurodevelopmental and growth outcomes of extremely low birth weight infants after necrotizing enterocolitis. Pediatrics 2005, 115(3):696-703.
303. Manzoni P., Maestri A., Leonessa M., et al. Fungal and bacterial sepsis and threshold ROP in preterm very low birth weight neonates. J Perinatol 2006, 26(1):23-30.
304. Wong H.R., Cvijanovich N., Lin R., et al. Identification of pediatric septic shock subclasses based on genome-wide expression profiling. BMC Med 2009, 7:34.
305. Wong H.R., Cvijanovich N., Allen G.L., et al. Genomic expression profiling across the pediatric systemic inflammatory response syndrome, sepsis, and septic shock spectrum. Crit Care Med 2009, 37(5):1558-1566.
306. Wong H.R., Odoms K., Sakthivel B. Divergence of canonical danger signals: the genome-level expression patterns of human mononuclear cells subjected to heat shock or lipopolysaccharide. BMC Immunol 2008, 9:24.
307. Cvijanovich N., Shanley T.P., Lin R., et al. Validating the genomic signature of pediatric septic shock. Physiol Genomics 2008, 34(1):127-134.
308. Shanley T.P., Cvijanovich N., Lin R., et al. Genome-level longitudinal expression of signaling pathways and gene networks in pediatric septic shock. Mol Med 2007, 13(9-10):495-508.
309. Tang B.M., McLean A.S., Dawes I.W., et al. Gene-expression profiling of Gram-positive and Gram-negative sepsis in critically ill patients. Crit Care Med 2008, 36(4):1125-1128.
310. Tang B.M., McLean A.S., Dawes I.W., et al. The use of gene-expression profiling to identify candidate genes in human sepsis. Am J Respir Crit Care Med 2007, 176(7):676-684.
311. Tang B.M., McLean A.S., Dawes I.W., et al. Gene-expression profiling of peripheral blood mononuclear cells in sepsis. Crit Care Med 2009, 37(3):882-888.
312. Karvunidis T., Mares J., Thongboonkerd V., et al. Recent progress of proteomics in critical illness. Shock 2009, 31(6):545-552.
313. Buhimschi C.S., Bhandari V., Hamar B.D., et al. Proteomic profiling of the amniotic fluid to detect inflammation, infection, and neonatal sepsis. PLoS Med 2007, 4(1):e18.
314. Feezor R.J., Cheng A., Paddock H.N., et al. Functional genomics and gene expression profiling in sepsis: beyond class prediction. Clin Infect Dis 2005, 41(Suppl 7):S427-S435.
315. Levy O., Sisson R.B., Kenyon J., et al. Enhancement of neonatal innate defense: effects of adding an N-terminal recombinant fragment of bactericidal/permeability-increasing protein on growth and tumor necrosis factor-inducing activity of Gram-negative bacteria tested in neonatal cord blood ex vivo. Infect Immun 2000, 68(9):5120-5125.
316. Reinhart K., Gluck T., Ligtenberg J., et al. CD14 receptor occupancy in severe sepsis: results of a phase I clinical trial with a recombinant chimeric CD14 monoclonal antibody (IC14). Crit Care Med 2004, 32(5):1100-1108.
317. Lauterbach R., Pawlik D., Kowalczyk D., et al. Effect of the immunomodulating agent, pentoxifylline, in the treatment of sepsis in prematurely delivered infants: a placebo-controlled, double-blind trial. Crit Care Med 1999, 27(4):807-814.
318. Tracey K.J. Physiology and immunology of the cholinergic antiinflammatory pathway. J Clin Invest 2007, 117(2):289-296.
319. Pleiner J., Schaller G., Mittermayer F., et al. Simvastatin prevents vascular hyporeactivity during inflammation. Circulation 2004, 110(21):3349-3354.
320. Ikegami M., Carter K., Bishop K., et al. Intratracheal recombinant surfactant protein d prevents endotoxin shock in the newborn preterm lamb. Am J Respir Crit Care Med 2006, 173(12):1342-1347.
321. Mohan P., Abrams S.A. Oral lactoferrin for the treatment of sepsis and necrotizing enterocolitis in neonates [review]. Cochrane Database Syst Rev 2009, 1:CD007138.
322. Venkatesh M., Abrams S. Can lactoferrin prevent neonatal sepsis and necrotizing enterocolitis?. Expert Rev Anti Infect Ther 2009, 7(5):515-525.
323. Suri M., Harrison L., Van de Ven C., et al. Immunotherapy in the prophylaxis and treatment of neonatal sepsis. Curr Opin Pediatr 2003, 15(2):155-160.